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Abstract: We compared the hypertrophic effects of clenbuterol, a 2-adrenergic agonist, on the masseter, digastric, and 
temporalis with those on the tongue, tibialis anterior, soleus, diaphragm, and heart. The weights of masseter, digastric and 
temporalis in the clenbuterol group were 36 ~ 56% greater than those in the control group, whereas those of the tibialis an-
terior, diaphragm, and heart weights in the clenbuterol group were 9 ~ 33% greater than those in the control group. No 
significant difference in the weights of the soleus and tongue was found between the control and clenbuterol groups. 
Taken together with our present and previously reported results, it is suggested that the hypertrophic effects of clenbuterol 
on the masseter, digastric, and temporalis are greater than those on the limb, trunk, and heart. 
Keywords: Clenbuterol, hypertrophic effects, striated muscles, rat. 
INTRODUCTION 
Clenbuterol [4-amino- (t-butyl-amino) methyl-3,5-
dichlorobenzyl alcohol] is a 2-adrenergic agonist and non-
steroidal anabolic drug for sports doping. According to the 
recent World Anti-Doping Agency documents, the use of 
clenbuterol was the fifth most common case in the number of 
anabolic drugs–used contravention in 2006 (53 cases) [1]. 
Clenbuterol is known to induce hypertrophy of skeletal mus-
cles such as the soleus, gastrocnemius, and extensor digito-
rum longus, as well as on the masseter and heart muscles [2-
10]. The precise mechanism for the hypertrophy of skeletal 
and cardiac muscles induced by clenbuterol remains un-
known. One leading hypothesis is that clenbuterol induces 
the hypertrophy of the skeletal muscles through the 2-
adrenergic receptor by up-regulating the expression of insu-
lin-like growth factors (IGFs) [7, 11-13] which play essential 
roles in the development, growth, and regeneration of skele-
tal muscles [14-20]. 
Muscle satellite cells are mononucleated and quiescent 
stem cells that reside between the sarcolemma and basal lam-
ina of adult myofibers [21,22]. In response to stimuli such as 
mechanical loading, unloading, denervation, and injury, the 
satellite cells are activated through several growth factors 
containing IGFs and this activation is thought to induce 
adaptive changes of skeletal muscle such as hypertrophy, the 
alteration of fiber type, and regeneration [16, 21-23]. Re-
cently, we have reported that the pool size of satellite cells in 
the masseter muscle of the muscle dystrophy model mouse 
(mdx) is greater than those of other muscles such as the gas-
trocnemius, soleus, and diaphragm [24] and we hypothesized  
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that the hypertrophic effect of clenbuterol on the craniofacial 
muscles containing the masseter muscle is greater than on 
other muscles.  
In the present study, to test this hypothesis, we measured 
the wet weights of masseter, temporalis, digastric and tongue 
muscles, and compared them with those of tibialis anterior, 
soleus, diaphragm, and heart muscles after oral administra-
tion of clenbuterol for 3 weeks. Furthermore, to exclude the 
possibility that clenbuterol secondarily leads to the hypertro-
phy of the masseter, temporalis, and digastric muscles by 
directly inducing the hypertrophy of the mandible and max-
illa, we measured the distance between the origin and inser-
tion of the muscles by three-dimensionally reconstructing the 
images of micro-computed tomography (μCT). 
MATERIALS AND METHODS 
Experimental Animals, Administration of Clenbuterol, 
and Weighing Muscles 
Ten male Wistar rats were purchased from Clea Japan, 
Inc., (Tokyo, Japan) and fed a hard diet (CE-2; Clea Japan, 
Inc., Tokyo, Japan). They were divided into control and 
clenbuterol groups of five rats each at 8 weeks of age. We 
orally administered 30 μg/ml of clenbuterol (C5423; Sigma-
Aldrich Fine Chemicals, St. Louis, MO, USA) to the rats in 
the clenbuterol group via their drinking water for 3 weeks, 
while pure water was given to the rats in the control group. 
We daily measured the weight of each rat and consumption 
of pure water or water containing clenbuterol for each rat to 
estimate the daily dose of clenbuterol. The dose of clen-
buterol was approximately 4 mg/kg of body weight/day. Af-
ter 3 weeks, all the animals were killed by exsanguinations 
under ether anesthesia. The masseter, temporalis, digastric 
(anterior belly), tongue, tibialis anterior, soleus, diaphragm, 
and heart were immediately dissected and weighed. After 
removing the muscles, the whole heads were frozen and 192    The Open Dentistry Journal, 2009, Volume 3  Ishikawa et al. 
stored in -30°C until subsequent μCT analysis. Experimental 
protocols concerning animal handling were reviewed and 
approved by the Institutional Animal Care Committee of 
Tsurumi University School of Dental Medicine.  
Morphometric Analysis of Rat Head by Micro-Computed 
Tomography (μCT) 
The distance between the origin and insertion of masse-
ter, digastric and temporalis muscles are analyzed by three-
dimensionally reconstructing the images of μCT. The whole 
head of the rat was transversely scanned at 750 μm intervals 
with a μCT system (LCT-100, ALOKA CO., LTD., Tokyo, 
Japan). The images at a resolution of 480 X 480 pixels were 
reconstructed in three directions using image analysis soft-
ware (Amira 3.1, Mercury Computer Systems, San Diego, 
CA) and the distances between the origin and insertion of 
masseter, digastric and temporalis muscles on the mandible 
and maxilla were measured on the three-dimensional images. 
Fig. (1) shows the measured points for the origins and inser-
tions of masseter, temporalis and digastric muscles on the 
mandible and maxilla. 
Statistical Analysis 
A Mann-Whitney U-test was used to compare the median 
values between the clenbuterol and control groups. 
RESULTS 
Fig. (2) shows box and whisker plots of the body weight 
in the control and clenbuterol groups at 21 days of clen-
buterol administration. In the plot, the dots represent the me-
dian value, the boxes represent the interquartile range, and 
the whiskers represent the full range of data. The median 
values of the body weight in the clenbuterol and control 
groups were 414 g and 449 g, respectively, with no statisti-
cally significant difference between the two groups.  
Fig. (3) shows box and whisker plots of the masseter (A), 
digastric (B), temporalis (C), and tongue (D) weights in the 
control and clenbuterol groups at 21 days of clenbuterol ad-
ministration. The median values of the masseter, digastric, 
and temporalis weights in the clenbuterol group were 1.588, 
0.147, and 0.762 g, which were 46, 36, and 56% greater than 
those in the control group (1.091, 0.108, and 0.490 g; 
p<0.01), respectively. The median values of the tongue 
weight in the clenbuterol and control groups were 0.375 and 
0.353 g, respectively, with no statistically significant differ-
ence between the two groups. 
Fig. (4) shows box and whisker plots of the tibialis ante-
rior (A), soleus (B), diaphragm (C), and heart (D) weights in 
the control and clenbuterol groups at 21 days of clenbuterol 
administration. The median values of the tibialis anterior, 
diaphragm, and heart weights in the clenbuterol group were 
1.111, 1.099, and 0.923 g, which were 33, 17, and 9% 
greater than those in the control group (0.837, 0.937, and 
0.845 g; p<0.05 ~ 0.01), respectively. The median values of 
the soleus weight in the clenbuterol and control groups were  
 
Fig. (1). Three-dimensionally reconstructed images of mandible and maxilla by μCT showing the measured points for the origins and inser-
tions of masseter (1, 2), temporalis (3, 4, 5), and digastric (6, 7) muscles.  
 
Fig. (2). Box and whisker plot of body weights in the control and 
clenbuterol groups after oral administration of clenbuterol for 3 
weeks. There were five rats in each group. No significant difference 
in the body weight was found between the control and clenbuterol 
groups. 
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Fig. (3). Box and whisker plots of weights of masseter (A), digastric (B), temporalis (C), and tongue (D) in the control and clenbuterol groups 
after oral administration of clenbuterol for 3 weeks. There were five rats in each group. Significant difference between the control and clen-
buterol groups, **p<0.01. The median values of the masseter, digastric, and temporalis weights in the clenbuterol group were 46, 36, and 
56% greater than those in the control group, respectively, but no significant difference in the tongue weight was found between the control 
and clenbuterol groups. 
 
Fig. (4). Box and whisker plots of weights of tibialis anterior (A), soleus (B), diaphragm (C), and heart (D) in the control and clenbuterol 
groups after oral administration of clenbuterol for 3 weeks. There were five rats in each group. Significant differences between the control 
and clenbuterol groups: *p<0.05, **p<0.01. The median values of the tibialis anterior, diaphragm, and heart weights in the clenbuterol group 
were 33, 17, and 9% greater than those in the control group, respectively, but no significant difference in the soleus weight was found be-
tween the control and clenbuterol groups. 194    The Open Dentistry Journal, 2009, Volume 3  Ishikawa et al. 
Table 1. The Distances (mm) Between the Origin and Insertion of Masseter, Digastric, and Temporalis Muscles Analyzed by μCT 
 Control  Clenbuterol  Significance   
Masseter     
1   9.87 ± 0.67   9.47 ± 0.74  NS 
2  19.90 ± 1.22  19.35 ± 0.39  NS 
Temporalis     
3  10.10 ± 0.63  10.49 ± 0.50     NS 
4  11.12 ± 0.66  12.07 ± 0.70     NS 
5  14.20 ± 1.09  15.44 ± 0.82     NS 
Digastric     
6  13.52 ± 1.22  13.18 ± 0.48  NS 
7   6.62 ± 1.05   7.05 ± 0.60  NS 
The distance was expressed as the mean ± standard deviation for five rats.  
 
Table 2. Reported Hypertrophic Rate of Murine Limb, Trunk, and Heart Muscles Induced by Clenbuterol 
Hypertrophic rate (%)  Dose 
(mg/kg/day) 
Duration 
(days) 
Method 
Sol Gas  PI  EDL  TA  DP 
Heart No.  of  Ref. 
0.01 14 M.P.  12 --  18  --  11  --  12 [25] 
0.25 7 S.C.  18  22  22  --  --  --  0 [26] 
0.25 56 S.C.  0 --  --  20  --  --  --  [6] 
1.0 14  S.C.  14  17  17  19  15  --  10  [27] 
1.0  21 S.C.  -- 5  --  --  --  --  -- [28] 
1.0  42 S.C.  17  --  --  --  --  --  -- [29] 
2.0 16  S.C.  --  13  --  --  --  --  0 [2] 
2.0  14 S.C.  6 18  15  --  --  --  -- [30] 
2.0 14  S.C.  --  19  --  --  --  --  -- [3] 
2.0  105  Oral  17  --  --  0 -- --  --  [31] 
3.0 9  M.P.  --  12  --  --  11  --  --  [14] 
# 14  Oral  8  24  --  19  --  --  --  [4] 
# 28  Oral  27  --  --  --  --  --  --  [5] 
4.0 21  Oral  0 --  --  --  33  17  9  * 
The percentage of the wet weight of the soleus (Sol), plantaris (PI), extensor digitorum longus (EDL), tibialis anterior (TA), diaphragm (DP), and heart are 
expressed relative to the control. Dashes (--) indicate that the muscle mass was not measured. S.C., M.P., and Oral denote subcutaneous injection, continuous 
injection by subcutaneously implanted osmotic mini-pump, and oral administration, respectively. *Data from the present study is included for comparison. #In 
these two studies, 30 μg/ml of clenbuterol was orally administered to animals via their drinking water and the exact dose of clenbuterol was not determined. 
 
0.186 and 0.218 g, respectively, with no statistically signifi-
cant difference between the two groups. 
To exclude the possibility that clenbuterol secondarily 
leads to the hypertrophy of the masseter, temporalis, and 
digastric muscles by directly inducing the hypertrophy of the 
mandible and maxilla, we measured the distance between the 
origin and insertion of the muscles by μCT (Table 1) and 
found no statistically significant differences in these dis-
tances. This result indicates that the hypertrophic effect of 
clenbuterol on masseter, temporalis, and digastric muscles is 
not a secondary effect. 
DISCUSSION 
In the present study, the hypertrophic rate associated with 
clenbuterol in the craniofacial muscles, including the masse-
ter, temporalis, and digastric muscles, ranged from 36 to Effects of Clenbuterol on the Size of Muscle  The Open Dentistry Journal, 2009, Volume 3    195 
56%, whereas those of the tibialis anterior, diaphragm, and 
heart ranged from 9 to 33%. Comparative data from previous 
studies of murine limb, trunk, and heart muscles are pre-
sented in tabular form in Table 2 [25]. The maximum value 
of the hypertrophic rate in the previous studies is 27%, 
which was induced in the soleus following 27 days of oral 
administration of 30 μg/ml of clenbuterol; the hypertrophic 
rates ranges from 0 to 27%. Since the dose, duration, and 
method of administration of clenbuterol varied among these 
studies, they are very difficult to compare with the present 
study. However, the hypertrophic rates shown in Table 2 are 
less than those of the craniofacial muscles in the present 
study. 
Muscle satellite cells are activated and induce adaptive 
changes of skeletal muscle such as hypertrophy, the altera-
tion of fiber type, and regeneration by external stimuli such 
as mechanical loading, unloading, denervation, and injury 
through growth factors such as IGFs, myostatin and IL-6 
[16,21-23,32,33]. We have reported that the pool size of sat-
ellite cells in the masseter muscle of a muscle dystrophy 
model mouse (mdx) is greater than those of other muscles 
such as the gastrocnemius, soleus, and diaphragm [24]. It 
also has been also reported that clenbuterol stimulates the 
activation, proliferation and differentiation of satellite cells 
[34-36] and, in the mouse disrupting 2 adrenergic receptor 
gene, clenbuterol is not able to induce the hypertrophy of 
skeletal muscles [14]. These reports suggest a direct relation-
ship among the satellite cells and hypertrophy of skeletal 
muscle induced by clenbuterol. In the present study, the 
clenbuterol-induced hypertrophic rates of craniofacial mus-
cles were greater than those of the tibialis anterior, soleus, 
and diaphragm muscles, and greater than those seen in pre-
vious studies. This result supports our hypothesis that the 
hypertrophic effect of clenbuterol on the craniofacial mus-
cles containing the masseter muscle is greater than on other 
muscles  
We found no significant difference induced by clen-
buterol in the weight of the tongue between the control and 
clenbuterol groups. Although the tongue muscles constitute a 
subset of the craniofacial muscles, the developmental origins 
of tongue muscles involves the hypaxial somites 2 ~5, and 
not the somitomeres, which are involved in the developmen-
tal origin of the craniofacial muscles [37-39]. Further, the 
program governing tongue myogenesis is similar to that for 
limb myogenesis and distinct from that for craniofacial myo-
genesis [40]. These differences may be responsible for the 
observed differences in the hypertrophic effect on tongue 
muscles by clenbuterol relative to the other craniofacial 
muscles such as the masseter, digastric, and temporalis. 
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